Search Results - "Reimund, J."

Refine Results
  1. 1
  2. 2
  3. 3

    Efficacy and safety of an olive oil‐based intravenous fat emulsion in adult patients on home parenteral nutrition by Reimund, J.‐M., Rahmi, G., Escalin, G., Pinna, G., Finck, G., Muller, C. D., Duclos, B., Baumann, R.

    Published in Alimentary pharmacology & therapeutics (15-02-2005)
    “…Summary Background : The most frequently used intravenous lipid emulsions are composed of 100% long chain triacylglycerols from soybean oil or of 50% long…”
    Get full text
    Journal Article
  4. 4

    Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey by REIMUND, J.-M., ARONDEL, Y., FINCK, G., ZIMMERMANN, F., DUCLOS, B., BAUMANN, R.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-02-2002)
    “…Background & Aims: Central venous catheter (CVC) infection is the most frequent complication during home parenteral nutrition (HPN). We prospectively assessed…”
    Get full text
    Journal Article
  5. 5

    Colon cancer in inflammatory bowel disease: recent trends, questions and answers by Viennot, S., Deleporte, A., Moussata, D., Nancey, S., Flourié, B., Reimund, J.-M.

    Published in Gastroentérologie clinique et biologique (01-06-2009)
    “…Patients with chronic colitis (ulcerative colitis or colonic Crohn's disease) have an increased risk of colorectal cancer (CRC). Although most of the molecular…”
    Get full text
    Journal Article
  6. 6

    Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease by Reimund, J M, Wittersheim, C, Dumont, S, Muller, C D, Kenney, J S, Baumann, R, Poindron, P, Duclos, B

    Published in Gut (01-11-1996)
    “…BACKGROUND: Increasing evidence points to a important role for inflammatory cytokines for the pathogenesis of Crohn's disease. AIM: To compare the secretion…”
    Get full text
    Journal Article
  7. 7

    Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease by REIMUND, J.-M, WITTERSHEIM, C, DUMONT, S, MULLER, C. D, BAUMANN, R, POINDRON, P, DUCLOS, B

    Published in Journal of clinical immunology (01-05-1996)
    “…Chronic inflammation in inflammatory bowel disease (IBD; Crohn's disease and ulcerative colitis) may be attributed partly to increased secretion of…”
    Get full text
    Journal Article
  8. 8

    Antioxidant and immune status in active Crohn's disease. A possible relationship by Reimund, J-M., Hirth, C., Koehl, C., Baumann, R., Duclos, B.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-02-2000)
    “…Background and aims: As reactive oxygen has been demonstrated to participate in immune genes transcription, the aim of this study was to examine the…”
    Get full text
    Journal Article
  9. 9

    Immune activation and nutritional status in adult Crohn's disease patients by Reimund, J.-M., Arondel, Y., Escalin, G., Finck, G., Baumann, R., Duclos, B.

    Published in Digestive and liver disease (01-06-2005)
    “…Recent attention focused on the effect of inflammatory cytokines on intermediary metabolism contributing to the nutritional disturbances observed in acute or…”
    Get full text
    Journal Article
  10. 10

    Cytokine gene expression during postnatal small intestinal development: regulation by glucocorticoids by Schaeffer, C, Diab-Assef, M, Plateroti, M, Laurent-Huck, F, Reimund, J M, Kedinger, M, Foltzer-Jourdainne, C

    Published in Gut (01-08-2000)
    “…BACKGROUND In the intestinal mucosa, numerous cytokines produced by the epithelium, fibroblasts, and immune cells were shown to affect epithelial…”
    Get full text
    Journal Article
  11. 11

    Estrogens control inflammation in experimental colitis by Hajj Hussein, I, Eid, A, Maksoud, R, Jambart, S, Bou Assi, T, Zgheib, Z, Oueidat, D, Chams, N, Chams, S, Diab, R, Barada, K, Jurjus, R, Cappello, F, Reimund, J, Kreiker, J, Leone, A, Jurjus, A

    “…There is now a wealth of experimental evidence indicating that the deficit in endogenous estrogen facilitates the onset of inflammation that can be antagonized…”
    Get more information
    Journal Article
  12. 12

    Urinary neopterin is a valuable tool in monitoring Crohn's disease activity by Nancey, S., Perret‐Liaudet, A., Moussata, D., Graber, I., Boschetti, G., Renaud, B., Kaiserlian, D., Reimund, J.M., Flourié, B.

    Published in Inflammatory bowel diseases (01-11-2008)
    “…Background: The aim was to investigate the relation between urinary neopterin and the Crohn's Disease Activity Index (CDAI) and to compare its ability to…”
    Get full text
    Journal Article
  13. 13

    Factors associated to hypermanganesemia in patients receiving home parenteral nutrition by REIMUND, J.-M., DIETEMANN, J.-L., WARTER, J.-M., BAUMANN, R., DUCLOS, B.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-10-2000)
    “…Background: Home parenteral nutrition (HPN) patients often present hypermanganesamia.Aim: To examine which factors may be associated to hypermanganesemia in…”
    Get full text
    Journal Article
  14. 14
  15. 15

    In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease by Reimund, J M, Dumont, S, Muller, C D, Kenney, J S, Kedinger, M, Baumann, R, Poindron, P, Duclos, B

    Published in Gut (01-04-1997)
    “…BACKGROUND: Inflammatory cytokines, including tumour necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1 beta, have been implicated as primary mediators…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Management of common bile duct stones in a single operation combining laparoscopic cholecystectomy and perioperative endoscopic sphincterotomy by MEYER, C, VO HUU LE, J, ROHR, S, THIRY, L. C, DUCLOS, B, REIMUND, J. M, BAUMANN, R

    Published in Surgical endoscopy (01-09-1999)
    “…Laparoscopic cholecystectomy (LC) has become the reference treatment for biliary lithiasis, but the management strategy for common bile duct stones (CBDS)…”
    Get full text
    Journal Article
  18. 18

    The Phosphodiesterase Inhibitor, Pentoxifylline, Alters Rat Intestinal Epithelial Cell Proliferation via Changes in the Expression of Transforming Growth Factors by Diab-Assef, M., Reimund, J. M., Ezenfis, J., Duclos, B., Kedinger, M., Foltzer-Jourdainne, C.

    “…Background: Phosphodiesterase (PDE) inhibitors, among which pentoxifylline (PTX), are candidate molecules for the treatment of TNF- α -dependent inflammatory…”
    Get full text
    Journal Article
  19. 19

    E010 Increase in circulating microparticles in inflammatory bowel disease patients induces vascular alterations by Leonetti, D, Tesse, A, Martinez, M.-C, Bretagne, A.-L, Reimund, J.-M, Andriantsitohaina, R

    “…Among the proposed hypothesis for inflammatory bowel disease (IBD) pathogenesis, a vascular cause has been suggested, mostly in reference to anatomic and…”
    Get full text
    Journal Article
  20. 20

    Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis by REIMUND, J.-M, ALLISON, A. C, MULLER, C. D, DUMONT, S, KENNEY, J. S, BAUMANN, R, DUCLOS, B, POINDRON, P

    Published in European journal of clinical investigation (01-02-1998)
    “…Background Modulation of cytokine secretion may be of interest in the treatment of Crohn's disease or ulcerative colitis. Methods The effect of three…”
    Get full text
    Journal Article